NCT00141518View on ClinicalTrials.gov

Long-term Study of Duodopa (Levodopa/Carbidopa) in Advanced Parkinson's: Health Outcomes & Net Economic Impact

PHASE4CompletedINTERVENTIONAL
Enrollment

77

Participants

Timeline

Start Date

March 31, 2006

Primary Completion Date

March 31, 2011

Study Completion Date

April 30, 2011

Conditions
Advanced Idiopathic Parkinson's Disease
Interventions
DRUG

Levodopa-carbidopa intestinal gel (LCIG)

DEVICE

CADD-Legacy® 1400 ambulatory infusion pump

DEVICE

percutaneous endoscopic gastrostomy tube (PEG tube)

DEVICE

jejunal extension tube (J-tube)

All Listed Sponsors
lead

AbbVie (prior sponsor, Abbott)

INDUSTRY

NCT00141518 - Long-term Study of Duodopa (Levodopa/Carbidopa) in Advanced Parkinson's: Health Outcomes & Net Economic Impact | Biotech Hunter | Biotech Hunter